Summit X LLC’s Globus Medical GMED Stock Holding History

Summit X LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-552	Closed	-$644	–	316
2020 Q3	$644	Buy	+552	New	+$28.5K	0.01%	283

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Summit X LLC's GMED Position: Q4 2020 in Review

Summit X LLC sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 552 shares — an estimated $644 sold.

Summit X LLC first reported a position in GMED in Q3 2020 and held it in 1 quarter. The position peaked at $644 in Q3 2020. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

Summit X LLC reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
Summit X LLC sold 552 Globus Medical shares in Q4 2020, an estimated $644.
Summit X LLC first reported a position in Globus Medical in Q3 2020 and held it in 1 quarter.
Summit X LLC's Globus Medical position peaked at $644 in Q3 2020.
348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Summit X LLC's 13F filing for Q4 2020, filed 29 Jan 2021.